Description
Description
Razor8 Blast Powder contains a full 4 g of Creatine and 1 g of highly bio-available Creatine HCI for rapid increases in strength and size. Razor8 Blast Powder features 640 mg of Arginine HCI, Pyroglutamate and Ethyl-Ester combined with 425 mf of CarnoSyn Beta-Alanine.
Multi-patented Nitrosigine is the latest in Nitric Oxide technology delivering 4 times the blood flow with truly impressive bioavailability and even more impressive results! Nitrosignine is so powerful that preliminary tests indicate 5 times the blood vessel expansion over Arginine HCI. The Nitrosignine molecule stability in the body appears to be the key ensuring rapid and sustained Nitric Oxide levels. Get the ultimate perpetual pump with 100% Fermentation derived Agmapure Agmatine Sulfate. HydroMax is a proprietary high-potency glycerol that functions to draw water away from skin and into the blood; get a more vascular drier look every time you train.
Benefits and features
- 30 Servings
- Advanced Polymethoxylated Energy Agent
- Highly Concentrated Pre-Workout Stimulant
- Agmapure 100% Fermentation Derived
- Ultra-Concentrated: 9.5 g Serving
- Higenamine HCI – Norcoclaurine – 45 mg
- Creatine 4,000 mg
- Creatine HCI 1,000 mg
- Nitrosigine 445 mg
- Beta-Alanine 425 mg
- Agmatine 365 mg
- Dietary Supplement
- Natural and Artificial Flavors Sweetened with Sucralose
- 100% Free of Artificial Dye or Color
- 100% Free of Aspartame
- 0 Sugars
- 0 Fillers
Disclaimer:
While Urban Nutrition Center strives to ensure the accuracy of its product images and information, some manufacturing changes to packaging and/or ingredients may be pending update on our site. Although items may occasionally ship with alternate packaging, freshness is always guaranteed. We recommend that you read labels, warnings, and directions of all products before use and not rely solely on the information provided by Urban Nutrition Center. The content on our site is not intended as medical advice or to replace information from a qualified healthcare professional.
